Keyphrases
16S rRNA Gene
8%
Acidification Rate
10%
Albumin
14%
Alcalase
22%
Alzheimer's Disease
9%
Anthracyclines
8%
Antioxidant
13%
Antioxidant Peptides
18%
ATP Secretion
12%
Avibacterium Paragallinarum
16%
Bovine Chromaffin Cells
32%
Breast Cancer
100%
Breast Cancer Patients
20%
Breast Cancer Subtypes
18%
Cancer Control
10%
Capsicum Annuum
16%
Catecholamine Secretion
16%
CD163
8%
Chenopodium Pallidicaule
16%
Chili Pepper
16%
Chromaffin Cells
16%
Chronic Disease
8%
Clinical Features
12%
Clinical Trials
10%
Confidence Interval
9%
Degree of Hydrolysis
10%
Depolarization
9%
Distillers Dried Grains with Solubles
16%
Docetaxel
8%
Early Breast Cancer
11%
Enterobacter
8%
EORTC
8%
Erythrina Edulis
24%
Estrogen Receptor-positive
12%
Extracellular Calcium
8%
Extremophilic
24%
Fast Component
9%
Fermentation Process Optimization
16%
Functional Food
8%
Functional Peptides
12%
Genetic Epidemiology
8%
Genomic Risk
8%
Glioblastoma
17%
Human Epidermal Growth Factor Receptor 2 (HER2)
16%
Hydrolysate
10%
Hydrolysis
20%
Hydrolyzate
22%
Immuno-oncology
25%
Indigenous Americans
19%
Inward Current
14%
Lupinus mutabilis
18%
Lymphocyte Level
8%
Malignancy
11%
Metabolic Alterations
10%
Microorganisms
10%
MINDACT
8%
Molecular Characterization
15%
Neoadjuvant
10%
Neoadjuvant Chemotherapy
9%
Neoadjuvant Therapy
9%
Nicotine
29%
Nicotinic Receptors
27%
Nutraceuticals
8%
Odds Ratio
10%
Oncology Biomarkers
25%
Ornithobacterium Rhinotracheale
10%
Overall Survival
19%
Oxidative Stress
16%
Pathologist
11%
Pepper Fruits
13%
Peru
41%
Peruvian
61%
Phase II Trial
16%
PIK3CA mutation
18%
Polymorphism
8%
Process Conditions
16%
Prognostic Factors
9%
Programmed Death-ligand 1 (PD-L1)
10%
Protease
36%
Protein Concentrate
10%
Proteolytic Activity
9%
Pseudomonas Aeruginosa (P. aeruginosa)
16%
Radiotherapy
10%
Recombinant
8%
Residual Disease
17%
Response Surface Methodology
24%
Risk Management
9%
Saline Environment
8%
Salterns
9%
Seed Storage Proteins
18%
Serine Protease
10%
Slow Component
9%
Soluble Protein
9%
Stromal Tumor-infiltrating Lymphocytes
18%
Tarwi
8%
Triple Negative
11%
Triple-negative Breast Cancer
36%
Tumor
22%
Tumor-infiltrating Immune Cells
16%
Tumor-infiltrating Lymphocytes
64%